Medications

Actemra approved for certain blood vessel inflammation

(HealthDay)—The injected drug Actemra (tocilizumab) has been approved by the U.S. Food and Drug Administration to treat adults with giant cell arteritis, an inflammation of the blood vessels (vasculitis).

Cardiology

New discovery on Giant Cell Arteritis sheds light on cause

New research from Queen Mary University of London has revealed – for the first time – how the condition Giant Cell Arteritis (GCA) may be caused by a certain group of white blood cells called 'neutrophils'. GCA (also ...